Healthpeak Properties (NYSE:DOC) PT Raised to $22.00 at Citigroup

Healthpeak Properties (NYSE:DOCGet Free Report) had its price objective boosted by equities researchers at Citigroup from $20.00 to $22.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has a “neutral” rating on the real estate investment trust’s stock. Citigroup’s target price points to a potential downside of 0.23% from the company’s previous close.

DOC has been the topic of a number of other reports. Evercore ISI upgraded Healthpeak Properties to a “strong-buy” rating in a research note on Monday, July 29th. BNP Paribas upgraded Healthpeak Properties from a “neutral” rating to an “outperform” rating and boosted their price objective for the company from $19.00 to $21.00 in a research note on Friday, April 26th. Scotiabank boosted their price objective on Healthpeak Properties from $22.00 to $23.00 and gave the company a “sector outperform” rating in a research note on Thursday, May 16th. JPMorgan Chase & Co. boosted their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company a “neutral” rating in a research note on Thursday, May 16th. Finally, StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and an average price target of $21.36.

View Our Latest Report on DOC

Healthpeak Properties Stock Performance

Shares of NYSE DOC traded up $0.16 during mid-day trading on Thursday, reaching $22.05. 740,454 shares of the company’s stock were exchanged, compared to its average volume of 5,831,024. The firm has a market capitalization of $15.52 billion, a price-to-earnings ratio of 63.00, a price-to-earnings-growth ratio of 2.71 and a beta of 1.11. Healthpeak Properties has a 52 week low of $15.24 and a 52 week high of $22.19. The company has a debt-to-equity ratio of 0.91, a current ratio of 0.70 and a quick ratio of 0.69. The firm has a 50-day moving average price of $20.60 and a two-hundred day moving average price of $18.32.

Healthpeak Properties (NYSE:DOCGet Free Report) last announced its quarterly earnings data on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23). Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%. The firm had revenue of $695.50 million during the quarter, compared to the consensus estimate of $665.11 million. During the same quarter in the prior year, the firm posted $0.45 earnings per share. The company’s revenue was up 27.5% on a year-over-year basis. Analysts predict that Healthpeak Properties will post 1.79 EPS for the current year.

Institutional Investors Weigh In On Healthpeak Properties

Institutional investors and hedge funds have recently modified their holdings of the company. Parallel Advisors LLC increased its position in shares of Healthpeak Properties by 274.6% in the fourth quarter. Parallel Advisors LLC now owns 4,072 shares of the real estate investment trust’s stock worth $54,000 after purchasing an additional 2,985 shares during the last quarter. Quadrant Capital Group LLC increased its position in shares of Healthpeak Properties by 645.4% in the fourth quarter. Quadrant Capital Group LLC now owns 9,646 shares of the real estate investment trust’s stock worth $128,000 after purchasing an additional 8,352 shares during the last quarter. Coldstream Capital Management Inc. bought a new position in shares of Healthpeak Properties in the fourth quarter worth approximately $153,000. International Assets Investment Management LLC increased its position in shares of Healthpeak Properties by 1,231.0% in the fourth quarter. International Assets Investment Management LLC now owns 12,125 shares of the real estate investment trust’s stock worth $161,000 after purchasing an additional 11,214 shares during the last quarter. Finally, Sapient Capital LLC bought a new position in shares of Healthpeak Properties in the fourth quarter worth approximately $165,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

About Healthpeak Properties

(Get Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Recommended Stories

Analyst Recommendations for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.